Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - Experience in 130 patients

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 1, 2013, Pages 129-136

  Schmidt, K J ^a   Herrlinger, K R ^b,c   Emmrich, J ^d   Barthel, D ^b   Koc, H ^b   Lehnert, H ^a   Stange, E F ^b   Fellermann, K ^a   Buning J ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

^c Asklepios Klinik Nord Heidberg   (Germany)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; TACROLIMUS;

ABDOMINAL DISCOMFORT; ADULT; AGED; CHILD; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COLON RESECTION; CREATININE BLOOD LEVEL; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY (TOPIC); NAUSEA; OPPORTUNISTIC INFECTION; PANCOLITIS; PARESTHESIA; PREDICTION; PRIORITY JOURNAL; PROCTITIS; REMISSION; REVIEW; SCHOOL CHILD; SHORT COURSE THERAPY; SIDE EFFECT; SURVIVAL RATE; TREATMENT DURATION; TREMOR; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870617265     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12118     Document Type: Review

References (28)

1. Truelove SC, Witts LJ,. Cortisone in the treatment of ulcerative colitis. Final report of a therapeutic trial. Br Med J 1955; 2: 1041-5.
2. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al,. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255-60.
3. Ho GT, Chiam P, Drummond H, et al,. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5 year UK inception cohort. Aliment Pharmacol Ther 2006; 24: 319-30.
4. Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A,. Clinical course of ulcerative colitis. Dig Liver Dis 2008; 40: 247-52.
5. Sjöberg M, Walch A, Meshkat M, et al,. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis 2011; 18: 212-8.
6. Laharie D, Boureille A, Branche J, et al,. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012 [Epub ahead of print].
7. Maser EA, Villela R, Silverberg MS, et al,. Assciation of through serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Clin Gastroenterol Hepatol 2006; 4: 1248-54.
8. Fellermann K, Ludwig D, Stahl M, et al,. Steroid-unresponsive acute attacks of inflammatory bowel disease immunomodulation by tacrolimus (FK506). Am J Gastroenterol 1998; 93: 1860-6.
9. Fellermann K, Tanko Z, Herrlinger KR, et al,. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis 2002; 8: 317-24.
10. Högenauer C, Wenzl HH, Hinterleitner TA, et al,. Effect of oral tacrolimus (FK506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther 2003; 18: 415-23.
11. Baumgart DC, Wiedemann B, Dignass AU,. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 2003; 17: 1273-81.
12. Ogata H, Matsui T, Nakamura M, et al,. A randomized dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 2006; 55: 1255-62.
13. Ogata H, Kato J, Hirai F, et al,. Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis. Inflamm Bowel Dis 2012; 18: 803-8.
14. Colombel JF, Sandborn WJ, Reinisch W, et al,. Infliximab, azathioprine or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-95.
15. Panaccione R, Gosh S, Middleton S, et al,. Infliximab, azathioprine or infliximab and azathioprine for treatment of moderate to severe ulcerative colitis: the UC SUCCESS trial. ECCO Congress 2012 [Abstract].
16. Baumgart DC, Pintoffl JP, Sturm A, et al,. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease-a long-term follow-up. Am J Gastroenterol 2006; 101: 1048-56.
17. Cohen RD, Stein R, Hanauer SB,. Intravenous cyclosporine in ulcerative colitis: a five-year experience. Am J Gastroenterol 1999; 94: 1587-92.
18. Lichtiger S, Daniel HD, Present MD, et al,. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 26: 1841-5.
19. Hart AL, Ng SC,. Review article: the optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther 2010; 32: 615-27.
20. Ananthakrishan A, Issa M, Beaulieu D, et al,. History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 176-81.
21. Dinesen L, Walsh A, Cummings JRF, et al,. The pattern and outcome of acute severe colitis. J Crohns Colitis 2010; 4: 431-7.
22. Bojic D, Radojicic Z, Nedeljkovic-Protic M, et al,. Long-term outcome after admission for acute severe ulcerative colitis in Oxford. Inflamm Bowel Dis 2009; 15: 823-8.
23. Travis SPL, Farrant JM, Ricketts C, et al,. Predicting outcome in severe ulcerative colitis. Gut 1996; 38: 905-10.
24. Rutgeerts P, Sandborn WJ, Geagan BG, et al,. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-76.
25. Järnerot G, Hertervig E, Friis-Liby I, et al,. Infliximab as rescue therapy in severe to moderate ulcerative colitis: a randomized placebo-controlled study. Gastroenterology 2005; 128: 1805-11.
26. Lichtiger S,. Treatment of choice for acute severe steroid-refractory ulcerative colitis is cyclosporine. Inflamm Bowel Dis 2009 Jan; 15: 141-2.
27. Carbonnel F, Lavergne A, Lemann M, et al,. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994; 39: 1550-7.
28. Moskovitz DN, Van Assche G, Maenhout B, et al,. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006; 4: 760-5.